Whole Blood Chloroquine Concentrations with Plasmodium vivax Infection in Irian Jaya, Indonesia

J. Kevin BairdU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by J. Kevin Baird in
Current site
Google Scholar
PubMed
Close
,
Budi LeksanaU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by Budi Leksana in
Current site
Google Scholar
PubMed
Close
,
Sofyan MasbarU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by Sofyan Masbar in
Current site
Google Scholar
PubMed
Close
,
SuradiU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by Suradi in
Current site
Google Scholar
PubMed
Close
,
M. Awaludin SutanihardjaU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by M. Awaludin Sutanihardja in
Current site
Google Scholar
PubMed
Close
,
David J. FryauffU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by David J. Fryauff in
Current site
Google Scholar
PubMed
Close
, and
Budi SubiantoU.S. Naval Medical Research Unit No. 2, Provincial Health Service, Jakarta, Indonesia

Search for other papers by Budi Subianto in
Current site
Google Scholar
PubMed
Close
Restricted access

Whole blood concentrations of self-administered chloroquine (CQ) and its metabolite desethylchloroquine (DCQ) were measured in 168 patients with microscopically confirmed infection by Plasmodium vivax in northeastern Irian Jaya, Indonesia. The study consisted of both survey and passive case detection in four separate villages between 1992 and 1994. The subjects were Javanese people 4–51 years old who had lived in the Arso region for up to two years. The sum of CQ and DCQ ranged from 0 to 8,342 ng/ml of whole blood, and 122 subjects (73%) had ≥ 100 ng/ml of CQ plus DCQ, the estimated minimally effective concentration (MEC) in whole blood against chloroquine-sensitive P. vivax. Among 56 subjects reporting to a clinic with symptoms of malaria, 53 (95%) had ordinarily effective levels of chloroquine in blood. Among 109 largely asymptomatic malaria patients found by survey case detection, 69 (63%) had chloroquine blood levels greater than the MEC. Virtually all clinical and most subclinical vivax malaria in this region occurs despite ordinarily effective levels of chloroquine in blood.

Save